Verrica Pharmaceuticals (VRCA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

VRCA Verrica Pharmaceuticals

Watchlist

0.730
+0.014+1.91%

Close Jan 23 16:00 ET

0.700
-0.030-4.07%

Post 20:01 ET

66.11MMarket Cap-0.40P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Trump Rolls Back Effort to Lower Medicare, Medicaid Drug Costs
MarketWatchJan 21 22:33 ET
Verrica Pharmaceuticals Announces Presentation of Three Posters, Data on VP-315
TipRanksJan 21 07:10 ET
Express News | Verrica Pharmaceuticals Announces Presentation of Three Posters Featuring Positive Preliminary Topline Results of Vp-315 for the Treatment of Basal Cell Carcinoma at the 2025 Winter Clinical Dermatology Conference
ReutersJan 21 07:00 ET
Verrica Pharmaceuticals Announces Presentation of Three Posters Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2025 Winter Clinical Dermatology Conference
GlobeNewswireJan 21 07:00 ET
Jefferies Maintains Verrica Pharmaceuticals(VRCA.US) With Buy Rating, Cuts Target Price to $3
Moomoo NewsJan 6 20:33 ET · Ratings
Needham Maintains Verrica Pharmaceuticals(VRCA.US) With Hold Rating
Moomoo NewsDec 20, 2024 14:31 ET · Ratings

Comments

Jaguar8

Jan 21 06:05

NEWS

$Verrica Pharmaceuticals (VRCA.US)$
Verrica Pharmaceuticals Announces Presentation of Three Posters Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2025 Winter Clinical Dermatology Conference
Tuesday, 21st January at 7:00 am
– Presented data includes a 97% Calculated Objective Response Rate (ORR) of study subjects following treatment with VP-315
– Posters highlight the safety data, tolerability data, and antitumor efficacy data of VP-3...

Jaguar8

Dec 6, 2024 07:00

NEWS

$Verrica Pharmaceuticals (VRCA.US)$
Verrica Pharmaceuticals Announces that Development Partner Torii Pharmaceutical Files New Drug Application of TO-208 the Treatment of Molluscum Contagiosum in Japan
Friday, 6th December at 8:00 am
WEST CHESTER, Pa., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (NASDAQ: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced its develop...

Teddy123

Oct 24, 2024 06:14

Verrica Pharmaceuticals Announces Acceptance of Two Abstracts Featuring Positive Preliminary Topline Results of VP-315 for the Treatment of Basal Cell Carcinoma at the 2024 Fall Clinical Dermatology C

$Verrica Pharmaceuticals (VRCA.US)$
WEST CHESTER, Pa., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced the acceptanc...